Allen & Overy advises Cathay Capital on its investment in medifa healthcare group
31 juillet 2019
Allen & Overy has advised Cathay Capital Private Equity on the acquisition of a minority stake in medifa healthcare group GmbH, a globally active medical technology company. The completion of the transaction is subject to the approval of the competent merger authorities.
Based in Rastatt, Germany, medifa healthcare group operates internationally in the medical technology sector. The product portfolio includes operating tables and accessories, examination chairs, as well as modular wall, door and ceiling systems. The medifa healthcare group operates three sites in Germany with approx. 350 employees. Planning, development and production are performed in Germany only.
Cathay Capital Private Equity is a leading international private equity firm focused on innovative cross-border investments, committed to supporting the growth and international expansion of its portfolio companies in Europe, North America, and China. Cathay is based in Paris, Munich, New York, the Silicon Valley, Shanghai, and Beijing. With approx. EUR 3 billion in assets under management, Cathay has invested in more than 100 companies across three continents. The investment in medifa healthcare group is funded from Cathay Capital's Sino-French (SME) Fund II.
The Allen & Overy team was led by partner Dominik Stühler and counsel Dr Kai Terstiege (both Private Equity, Munich) and included partners Dr Heike Weber (Tax, Frankfurt) and Dr Jens Matthes (IP, Düsseldorf), counsels Dr René Galle (Antitrust, Hamburg) and Peter Wehner (Pensions, Frankfurt), senior associates Tobias Hoppe (Private Equity, Munich), Dr Sebastian Schulz (Employment, Frankfurt) and Eda Zhuleku (Life Science, Munich), as well as associates Elisabeth Pichler (Private Equity, Munich), Sven Bischoff (Tax, Frankfurt), Dr Till Goeckler (Antitrust, Hamburg) and Melissa Baudewig (IP, Düsseldorf).